A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

The way the world defines obesity has been in need of an overhaul, according to some experts, and it could be coming soon ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

A study shows GLP-1 weight-loss drugs reduce Alzheimer’s risk but increase arthritis, kidney, and pancreas issues.

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health, but ...